Mirae Asset Global Etfs Holdings Ltd. Rapt Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,313 shares of RAPT stock, worth $26,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,313
Previous 14,643
11.4%
Holding current value
$26,427
Previous $44,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
104Shares Held
27.1MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$5.11 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$4.34 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$3.95 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.79 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$2.59 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $48M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...